Even before integrating into existing circuitry, adultborn neurons express receptors for neurotransmitters, but the intercellular mechanisms and their impact on neurogenesis remain largely unexplored. Here, we show that neuroblasts born in the postnatal subventricular zone (SVZ) acquire NMDA receptors (NMDARs) during their migration to the olfactory bulb. Along their route, neuroblasts are ensheathed by astrocyte-like cells expressing vesicular glutamate release machinery. Increasing calcium in these specialized astrocytes induced NMDAR activity in neuroblasts, and blocking astrocytic vesicular release eliminated spontaneous NMDAR activity. Single-cell knockout of NMDARs using neonatal electroporation resulted in neuroblast apoptosis at the time of NMDAR acquisition. This cumulated in a 40% loss of neuroblasts along their migratory route, demonstrating that NMDAR acquisition is critical for neuroblast survival prior to entering a synaptic network. In addition, our findings suggest an unexpected mechanism wherein SVZ astrocytes use glutamate signaling through NMDARs to control the number of adult-born neurons reaching their final destination.
INTRODUCTION
Accumulating evidence suggests that the neurotransmitters GABA and glutamate are essential signaling molecules that control adult neurogenesis (Bordey, 2006 (Bordey, , 2007 Ge et al., 2007; Platel et al., 2008a) . Neurogenesis persists in two centers in the adult mammalian brain, the subventricular zone (SVZ) and the hippocampal dentate gyrus (Lledo et al., 2006; Zhao et al., 2008) . In the SVZ, neural stem cells, a subpopulation of astrocyte-like cells, produce transit amplifying cells, which themselves generate neuroblasts (Doetsch et al., 1999) . Neuroblasts migrate in chains ensheathed by astrocyte-like cells (also called SVZ and RMS astrocytes) throughout the SVZ and along the rostral migratory stream (RMS) to the olfactory bulb (OB) (Lois et al., 1996; Peretto et al., 1997) . Once in the RMS of the OB, they turn and migrate radially to enter the existing OB circuitry and differentiate into interneurons (granule cells and periglomerular cells) (Luskin, 1993; Lois and Alvarez-Buylla, 1994) .
Prior to entering the OB circuitry, neuroblasts develop in an asynaptic environment, yet neurotransmitters seem to play a prominent role in their development. In the SVZ and RMS, GABA is released by neuroblasts to activate GABA A receptors in both neuroblasts and astrocyte-like stem cells, and is then taken up by astrocyte-like cells (Stewart et al., 2002; Wang et al., 2003b; Bolteus and Bordey, 2004; Liu et al., 2005) . Ultimately, GABA exerts a tonic control of the production of neuroblasts in the postnatal SVZ by limiting the proliferation of astrocyte-like stem cells (Liu et al., 2005) and neuroblasts (Nguyen et al., 2003) . Glutamatergic signaling in the SVZ remains largely unexplored. SVZ and RMS neuroblasts express functional metabotropic and ionotropic AMPA/kainate-type glutamate receptors (Di Giorgi-Gerevini et al., 2005; Platel et al., 2007b Platel et al., , 2008b . These receptors are tonically activated and have been shown to regulate neuroblast proliferation and migration, respectively (Di Giorgi-Gerevini et al., 2005; Platel et al., 2008b) . Despite the tonic activation of these receptors, the source of glutamate in the SVZ and RMS is unknown.
Here, we present surprising evidence that neuroblasts express functional NMDARs prior to entering the OB, contrary to previous work (Carleton et al., 2003) . Therefore, we hypothesized that glutamate acting on NMDARs is a neurotrophic signal from SVZ/RMS astrocytes to neuroblasts en route to the OB. We tested for the presence and function of a glutamate signaling system in the postnatal SVZ/RMS using a combination of anatomical and functional approaches. We confirmed functional, activity-dependent, vesicular glutamatergic signaling from astrocyte-like cells to neuroblasts. Further, we used single-cell genetic removal of functional NMDARs in neuroblasts to examine their potential functional role in cell migration and survival. We found that NMDARs unexpectedly provide early survival cues to neuroblasts prior to entering an existing synaptic network. Glutamatergic signaling through NMDARs is, therefore, critical in controlling the number of neurons that reach the OB.
RESULTS

Neuroblasts Acquire NMDARs during Their Migration toward the Olfactory Bulb
To determine whether neuroblasts express functional NMDARs in the SVZ and RMS, we obtained gramicidin-perforated patch-clamp recordings from neuroblasts in acutely dissected sagittal brain slices at near-physiological temperature (32 C-35 C) from mice of age postnatal day (P) 20 to 30 unless otherwise mentioned. Recorded cells were identified as neuroblasts based on their ionic signature and biophysical properties (Wang et al., 2003a (Wang et al., , 2003b Bolteus and Bordey, 2004) that are significantly different from the properties of SVZ astrocytes (Liu et al., 2005 (Liu et al., , 2006 ; neuroblasts have high input resistances (4.5 ± 0.1 GU, n = 203) and mean depolarized zero-current resting potentials (À25 mV), whereas SVZ astrocytes have low input resistance (50-100 MU, n = 26) and hyperpolarized resting potentials (À80 mV). Neuroblasts were recorded in a Mg 2+ -free solution containing 10 mM glycine, to enhance NMDAR activation, and antagonists of both glycine and GABA A receptors (10 mM strychnine and 20 mM bicuculline, respectively) unless otherwise stated. Recordings were performed at different locations along the SVZ-RMS axis: along the lateral wall of the lateral ventricle (SVZ), in the rostral SVZ under the corpus callosum (rSVZ), in the RMS elbow (RMS EL ), and in the RMS of the OB (RMS OB ) where neuroblasts turn radially to enter the granule cell layer (see Figure 1H ). The term RMS refers to both RMS EL and RMS OB . Pressure applications of NMDA (50-100 mM, (A) Perforated patch-clamp records of neuroblasts at different positions along the caudal-rostral axis en route to the olfactory bulb. The different locations, including the SVZ along the lateral ventricle, the rostral SVZ (rSVZ), the RMS EL (EL for elbow), and the RMS of the olfactory bulb (RMS OB ), are illustrated on a sagittal section in (H). Pressure application of 100 mM NMDA (5 s) induced inward currents in rSVZ and RMS, but not SVZ neuroblasts (held at À64 mV). Scale: 10 pA/5 s. percentage of cells that responded to NMDA with a current is indicated at each location. Scale: 500 mm. Inset: 100 mM NMDA-induced current in a RMS EL neuroblast from a P91 mouse. Scale: 2 pA/1 s. 5-10 s) induced no detectable currents in neuroblasts in the SVZ (n = 6, Figures 1A and 1B) . However, once in the rSVZ, some neuroblasts displayed NMDA-induced inward currents (n = 3/6, Figures 1A and 1B) that reversed at 0 mV (n = 8, Figure 1C ) and were markedly reduced by the competitive NMDAR antagonist D-2-amino-5-phosphonovaleric acid (D-APV, n = 7, see Box plot in Figure 5 ). Even in 3-month-old mice, pressure application of NMDA as short as 100 ms induced NMDA channel activity in RMS EL neuroblasts (n = 5/7, inset in Figure 1H ). In current clamp, NMDA-induced depolarizations of neuroblasts were significantly and reversibly reduced by D-APV (n = 4, Figure 1D ), identifying these responses as due to NMDAR activation. NMDA did not induce currents or calcium (Ca 2+ ) responses in SVZ or RMS astrocytes (n = 5, Figure 1E ), suggesting that these cells do not express functional NMDARs. Both the NMDA-induced charge transfer density (Q divided by the cell capacitance, C) and the percentage of recorded neuroblasts responding to NMDA (92% in the RMS OB ) increased significantly along the caudal to rostral axis ( Figure 1B , p < 0.05, one-way ANOVA).
To survey a larger number of neuroblasts and better determine the percentage expressing NMDARs, we used Ca 2+ imaging in transgenic mice where Green Fluorescent Protein (GFP) is fused to a nonendogenous G protein-coupled receptor called Mas-related gene A1 (MrgA1) that is only expressed in astrocytes (please see Figures 4A and 4B for additional information and data on these mice). As a result, GFP outlines the cell membranes of astrocytes, making them easily distinguishable from neuroblasts prior to and following loading of the Ca 2+ -sensitive dye Fluo-4 AM ( Figure 1D ). In addition, an agonist of the MrgA1 receptor (the phe-leu-arg-phe amide peptide, FLRFa) increased Ca 2+ in GFP-fluorescent cells. allowing further identification of the FLRFa-responding cells as astrocytes at the end of each experiment. Recordings were performed in solution containing 0.8 mM Mg 2+ , bicuculline, and no glycine at 33 C-35 C. Pressure application of NMDA (100 mM) induced transient increases in intracellular Ca 2+ in 60% rSVZ and >85% RMS neuroblasts (n = 4-11 recordings) but not FLRFa-responding cells, i.e. astrocytes (n = 61 cells, Figures 1E and 1F ). These Ca 2+ responses in neuroblasts were blocked by D-APV (n = 3 slices, data not shown). The percentage of neuroblasts responding to NMDA significantly increased along the caudal-rostral axis from 20% in the SVZ to 84% and 91% in the RMS EL and RMS OB , respectively (Figures 2G and 2H) . Collectively, these data report an increasing expression of functional NMDARs in neuroblasts during their migration along the rSVZ and RMS.
Most RMS Neuroblasts Display Spontaneous NMDAR Activity We next examined whether neuroblasts display spontaneous NMDAR activation, which would suggest the presence of ambient glutamate. Neuroblasts displayed spontaneous singlechannel events (sSCEs) illustrating phasic NMDAR activation ( Figure 2A , same recording conditions as in Figure 1 ). Gaussian fit of the channel amplitude histogram for the trace partly shown in Figure 2A gave an amplitude of À3.0 pA at À64 mV (right inset in Figure 2A ), resulting in a conductance of 47 pS (assuming a reversal potential of 0 mV) similar to that previously shown for NMDARs (Cull-Candy and Usowicz, 1987; Ascher et al., 1988) . Neuroblasts also displayed channels with smaller amplitudes (open columns, inset in Figure 2A ). To estimate SCE frequency we used a cut-off amplitude between À1.8 and À2.0 pA (depending on the noise) to measure channels with a conductance similar to that of NMDARs. The mean SCE amplitude from nine cells averaged À2.87 ± 0.04 pA at À64 mV, giving a conductance of 45 pS (data not shown). sSCE frequency was significantly and reversibly reduced to 15.7% ± 2.8% of control by D-APV (n = 23, Figure 2B ), identifying most of these events as NMDAR channel openings. As shown for NMDAinduced currents, the SCE frequency and the percentages of neuroblasts displaying sSCEs in the RMS EL and RMS OB (82% and 91% of the recorded neuroblasts, respectively) were significantly greater than those in the rSVZ (37%, p < 0.05, Figures 2C  and 2D ). We also examined whether phasic NMDAR activation occurred under near-physiological conditions of Mg 2+ (0.8 mM).
In voltage clamp, sSCEs were observed in neuroblasts (2.8 ± 0.9 Hz, n = 8/9 in RMS EL and RMS OB , data not shown). With D-APV, their frequency was reduced to 4.7% ± 2.3% of control.
In current clamp (in 0.8 mM Mg 2+ without bicuculline), spontaneous depolarizations in neuroblasts were reduced in amplitude and in frequency by 30%-40% during D-APV application (n = 4, Figure 2E ). Collectively, these data show that most neuroblasts in the RMS (>80%) receive a phasic glutamate signal via NMDAR activation.
Astrocytes of the Neurogenic Forebrain Express
Machinery for Vesicular Release of Glutamate We previously found that SVZ and RMS astrocytes, marked by glutamate-aspartate transporter (GLAST), displayed intense glutamate staining in the SVZ (Platel et al., 2007b) . Here, preembedding immunocytochemistry revealed that L-glutamate was concentrated in astrocytes and absent from other SVZ and RMS cells ( Figure 3A ). Astrocytes were identified based on their pale cytoplasm, and the expression of GLAST was examined on separate sections (data not shown). To determine whether SVZ astrocytes are capable of releasing glutamate in a vesicular manner, we examined the distribution of vesicular glutamate transporters (VGLUTs). The family of VGLUTs in mammals is composed of three highly homologous proteins, VGLUT1-3. Coimmunostaining for VGLUT1, GLAST (a marker of astrocytes; Bolteus and Bordey, 2004; Liu et al., 2006) , and doublecortin (DCX, a marker of neuroblasts; Gleeson et al., 1999) revealed that only astrocytes expressed VGLUT1 (Figure 3B, Synaptic Systems antibody; Figures S1A and S1B [available online] for NeuroMab antibody). No VGLUT2 or VGLUT3 immunostaining was observed in the RMS or SVZ, while VGLUT2 and VGLUT3 staining were present in the striatum and in the hippocampus, respectively, as expected (Figures S1C and S1G). Postembedding immunogold labeling for VGLUT1 also showed that only astrocytes contained VGLUT1 in the RMS and SVZ in electron micrographs ( Figure 3C ). We also immunostained for synaptobrevin 2 (also called VAMP2), a member of the v-SNARE complex that is essential for vesicular release (Sørensen, 2005) . Only astrocytes (GLAST + cells) in the SVZ/ RMS stained positive for synaptobrevin 2 ( Figure 3D ). In addition, coimmunostaining for VGLUT1 and synaptobrevin 2 revealed that VGLUT1 signal colocalized with synaptobrevin 2 signal (Figures S1I and S1J). However, not all synaptobrevin-2 + puncta colocalized with VGLUT1. This latter finding was expected because SVZ astrocytes release ATP in a vesicular manner in vitro (Striedinger et al., 2007) , and not all vesicles are readily releasable. While VGLUT1 and synaptobrevin 2 are expressed in neurons and in some mature astrocytes (Montana et al., 2004; Bezzi et al., 2004; Zhang et al., 2004; Boulland et al., 2004) , they are only expressed in astrocytes in the SVZ and RMS. The lack of VGLUT1 and synaptobrevin 2 in neuroblasts was expected because they synthesize and release GABA in a nonvesicular mechanism (Liu et al., 2005) . These data suggest that SVZ/RMS astrocytes may be a source of glutamate, likely releasing it in a vesicular and potentially Ca 2+ -dependent manner. 
Calcium Increases in RMS Astrocytes Lead to NMDAR Activity in Neuroblasts
We next explored whether RMS astrocytes release glutamate in a Ca
2+
-dependent manner that results in NMDAR activation in neuroblasts. We used transgenic mice that express MrgA1 in astrocytes to evoke Ca 2+ increases using the peptide agonist FLRFa that does not bind endogenous receptors in the brain (Fiacco et al., 2007) . The MrgA1 receptor fused to GFP was targeted to astrocytes using the inducible tet-off system. Mice expressing the tetracycline transactivator (tTA) under the human glial fibrillary acidic protein (GFAP) promoter were crossed to mice in which the MrgA1 receptor was transcribed off the tet (tetO) minimal promoter. In the SVZ of hGFAP-tTA x tetO-MrgA1 mice (referred to henceforth as MrgA1 + mice), GFP fused to MrgA1 is selectively expressed in SVZ astrocytes that are identified by GFAP and brain lipidbinding protein (BLBP) staining (Platel et al., 2009 ) ( Figure 4A ). GFP was not in DCX-immunopositive cells, i.e. neuroblasts (Figures S2A and S2B) . Pressure application of FLRFa (5 mM, 10 s) induced intracellular Ca 2+ increases in Fluo-4-AM-loaded cells that express MrgA1-GFP ( Figure 4B and Movie S1, available online). These data confirmed the MrgA1 + mouse line as a viable tool for selective stimulation of SVZ/RMS astrocytes, similar to the previous report in the hippocampus (Fiacco et al., 2007) .
We examined the effects of astrocytic stimulation by FLRFa on baseline NMDA channel activity in neuroblasts in acute sagittal slices from MrgA1 + mice at 32 C-35 C (see Figure 4C top for diagram). Using gramicidin-perforated patch-clamp recordings, tonic SCE frequency in RMS neuroblasts was significantly increased to 312% ± 35% of control upon bath application (5 mM, 60 s) of FLRFa (n = 9, p < 0.01, Figures 4C and 4D ). FLRFa did not induce a detectable change in channel amplitude (data not shown). The FLRFa-induced increase in channel activity was significantly reduced to 18% ± 5% of control by addition of 50 mM D-APV (n = 7, p < 0.01, Figures 4C and 4D ), identifying most of this activity as NMDAR mediated. In single transgenic mice (expressing only the tetO-MrgA1 construct, or MrgA1 À mice) FLRFa did not significantly increase SCE frequency (112% of control with FLRFa), although these neuroblasts showed D-APV-sensitive activity (19% of control in D-APV, n = 4, Figure 4D ). These control experiments show the effectiveness of the tet-off system in targeting MrgA1 to astrocytes and that FLRFa does not directly increase the frequency of NMDAR activity. Collectively, these data suggest that selective intracellular Ca 2+ increases in RMS astrocytes lead to glutamate release that activates NMDARs in neuroblasts.
Vesicular Release of Glutamate from Astrocytes Controls NMDAR Activity in Neuroblasts
To determine whether a vesicular pathway was involved in glutamate release, we perturbed two critical processes in the vesicular release pathway. First, we blocked vesicular refilling using the vacuolar H + -ATPase inhibitor concanamycin A (Drö se et al., 1993). Concanamycin A (5 mM, 4-5 hr preincubation) eliminated sSCEs (n = 5 cells, Figure 4G and traces in Figure S2C ). In addition, neuroblasts pretreated with concanamycin A still displayed NMDA-induced currents induced by pressure application of NMDA ( Figure S2C ), indicating that concanamycin A did not directly interfere with NMDARs. Second, we used two Clostridium botulinum neurotoxins (BoNT), A and B. BoNT/A cleaves the t-SNARE complex protein SNAP-25 in neurons and BoNT/B cleaves the v-SNARE complex protein synaptobrevin 2 in neurons and astrocytes (Araque et al., 2000; Schiavo et al., 2000) . Acute slices were incubated for 15-20 hr at room temperature in control artificial cerebrospinal fluid (aCSF) or aCSF containing 200 nM of either toxin. Neuroblasts in the RMS OB of sagittal slices incubated for 10-20 hr in control aCSF displayed channel activity at a frequency of 3.3 ± 0.8 Hz (n = 6) that was significantly reduced by D-APV (traces not shown, but see Figure 4G ). Incubation in BoNT/A did not significantly decrease SCE frequency in neuroblasts (3.1 ± 0.7 Hz, n = 5 compared to 3.3 Hz in control aCSF, Figures 4E and 4G ).
D-APV significantly reduced channel activity in BoNT/A-incubated neuroblasts (0.6 ± 0.3 Hz, n = 5), identifying this activity as mostly mediated by NMDARs. As a control, neurons in BoNT/A treated slices did not display spontaneous excitatory synaptic currents (n = 6/6, data not shown). However, incubation in BoNT/B resulted in a complete block of tonic NMDAR channel activity in neuroblasts (n = 6, Figures 4F and 4G ). This effect was not a direct blockade of NMDARs because NMDA application (10 mM) induced inward currents in neuroblasts (n = 4/4, Figure S2D ). Collectively, these data suggest that intracellular Ca 2+ -dependent vesicular fusion in astrocytes of the neurogenic forebrain contributes to glutamate release and NMDAR activation in migrating neuroblasts. 
Single-Cell Knockout of Functional NMDARs in Neuroblasts Using In Vivo Postnatal Electroporation
To explore the role of NMDAR in neurogenesis, we genetically removed NMDARs in individual neuroblasts using in vivo electroporation in neonatal mice (Boutin et al., 2008; Chesler et al., 2008) . We used transgenic NR1 fl/fl mice crossed with Rosa26-STOP-YFP reporter mice to generate NR1 fl /R26R-YFP mice (Y for yellow and fl for floxed). In NR1 fl mice the gene encoding the NMDAR subunit NR1, which is essential for NMDAR functionality, is flanked by loxP sites (i.e., floxed, fl, diagram in Figure 5A ). In R26R-YFP mice a STOP sequence is flanked by loxP sites, preventing YFP expression. Figures 5C and 5D ). It takes 7-11 days for neuroblasts born in the SVZ to reach the RMS OB (data not shown). At 7 days Figure 5D for 2 weeks). By 2 weeks postelectroporation, YFP + neurons were found in the granule cell layer ( Figure 5C ).
To assess the functional knockout of NR1 by Cre recombination, we used both patch-clamp recordings and Ca 2+ imaging to examine the loss of functional NMDARs in neuroblasts. Both patch-clamp recordings and Ca 2+ imaging were performed as described in Figure 1 . YFP + cells were identified prior to 
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Role of NMDA Receptors on SVZ Neurogenesis recordings or Fluo-4 AM loading and were neuroblasts as shown in Figure 5D (DCX + ). In the RMS OB from NR1 fl /R26R-YFP mice (acute slices), pressure applications of NMDA (100 mM, 5-10 s) induced no detectable currents in YFP + neuroblasts (n = 11/11, Figure 5F ), but NMDA induced currents in surrounding YFP À neuroblasts (n = 8/11) in the same slices (data not shown). Furthermore, in R26R-YFP control mice, application of NMDA induced currents in YFP + neuroblasts (n = 9/11, Figure 5E increases induced by NMDA and that electroporation and Cre expression has no effect on the expression of NMDARs. These data show that in vivo electroporation of a Cre-containing plasmid into SVZ cells of NR1 fl /R26R-YFP mice resulted in knockout of NR1 and loss of functional NMDARs in single neuroblasts born throughout postnatal life.
NMDAR Does Not Regulate Neuroblast Migration
We have previously monitored neuroblast migration in acute tissue using DIC or fluorescence visualization of GFP-expressing neuroblasts in DCX-GFP transgenic mice (Bolteus and Bordey, 2004; Platel et al., 2008b) . Here the fact that 20%-30% of RMS neuroblasts were YFP + allowed us to easily distinguish and track the same migrating neuroblasts in acute slices using time-lapse imaging ( Figure 6A ). The following experiments were performed at P25-P30 (fourth week postelectroporation) as was the case for most of the electrophysiology and Ca 2+ imaging data. We first examined whether genetic removal of NMDARs in RMS neuroblasts would affect their speed of migration. We found that YFP + neuroblasts migrated at similar speeds in acute slices from both R26R-YFP and NR1 fl /R26R-YFP mice (62.2 ± 2 mm/hr and 64.2 ± 2.7 mm/hr, respectively; n = 227 cells, six mice, and n = 100 cells, three mice; Figure 6B and Movie S2). Next, we examined the effect of 50 mM D-APV or 10 mM NMDA on the speed of RMS neuroblast migration in control R26-YFP mice. YFP + neuroblasts in such mice express functional NMDARs (see Figure 5E and 5H). In addition, NMDA pressure applied at 10 mM was sufficient to induce inward current in RMS neuroblasts ( Figure S2C ). During a 1 hr control movie, neuroblasts in the RMS migrated at 66.3 ± 2.4 mm/hr (n = 6 slices) and displayed classical saltatory movement (Movies S3 and S4 
In Vivo Blockade and Genetic Removal of NMDARs Decrease Neuroblast Survival
NMDARs have recently been shown to prevent apoptosis of adult-born granule neurons during their synaptic integration into the hippocampal network (Tashiro et al., 2006) . To examine whether NMDAR activity controls the survival of neuroblasts during their migration and before integration into the OB, we first injected an NMDAR blocker in vivo. Mice expressing GFP under the DCX promoter (DCX-GFP) mice received a single injection of the NMDAR open-channel blocker MK-801 (1 mg/kg). At different time points (2, 6, and 24 hr) following injection, staining for activated caspase 3 (a marker of apoptotic cells) was performed in sagittal slices to examine the number of apoptotic neuroblasts ( Figure 7A) . Quantification of the density of activated caspase 3 + neuroblasts (cell number divided by the volume) indicates that blockade of NMDARs resulted in a significant, >2-fold increase in the density of apoptotic neuroblasts in the rSVZ at 6 hr post-MK-801 injection (n = 4 mice per condition, p < 0.05, Figure 7B ). The number of apoptotic cells in the rSVZ returned to control levels by 24 hr. In the RMS EL blockade of NMDARs resulted in a significant, >2-fold increase in the density of apoptotic neuroblasts at each time point with a peak at 6 hr (Figures 7B). This result is consistent with the presence of neuroblasts with relatively high NMDAR channel frequency in the RMS (2-11 Hz) compared with the lower frequency in the rSVZ (<2 Hz, see Figure 2C and diagram in Figure 7D ). These data suggest that NMDAR activation is an important survival cue for neuroblasts migrating within the asynaptic environments of the RMS, before their integration in the synaptic circuitry of the OB. To next assess whether genetic removal of NMDARs selectively in neuroblasts resulted in increased apoptosis, we immunostained sagittal sections for activated caspase 3 and DCX in , corresponding to the end of the neonatal period and young adult age, respectively. In addition, apoptosis was examined in the rSVZ, the RMS, and the granule cell layer of the OB. We found that the percentage of activated caspase 3 + YFP + neuroblasts was significantly increased in the rSVZ and RMS at each time point (p < 0.05, Figure 7C ). There was also a significant increase in apoptosis of NR1 knockout (-KO) neurons in the granule cell layer at 4 and 8 weeks (p < 0.05). This increase in the number of apoptotic neuroblasts is unlikely to be due to Cre toxicity because control mice (R26-YFP) also received a Cre-containing plasmid. These data suggest that acquisition of NMDARs in neuroblasts, which occurs along the rSVZ and to a lesser extent in (D) Model illustrating the predicted effect of increased apoptosis on accumulated cell loss along the migratory route. Considering that $10,000 neuroblasts are born per day, $200 NR1-KO neuroblasts (1%-3%) will be apoptotic and cleared in $1 day. Since it takes $11 days for newly born neuroblasts to migrate from the SVZ to the RMS OB , apoptosis would lead to a total loss of $2,200 neuroblasts in the RMS OB , corresponding to 22% of the original neuroblast population.
the RMS EL ( Figure 7D ), is critical for their survival during their migration to the OB. In addition, such an increase in the percentage of apoptotic neuroblasts from less than 0.1% to 1%-3% following NR1 knockout suggests a significant reduction in the number of neuroblasts reaching the OB. Indeed, considering the estimate that $10,000 neuroblasts are born per day, $200 NR1-KO neuroblasts (1%-3%) will be apoptotic (activated caspase-3 + ) and then cleared in $1 day. Since its takes $11 days for all newly born neuroblasts to migrate from the SVZ to the RMS OB , apoptosis would result in a cumulated loss of $2,200 neuroblasts in the RMS OB , which corresponds to 22% of the original neuroblast population. This is a conservative estimate because activated caspase-3 + cells may be detectable for less than 24 hr, therefore resulting in an underestimation of the percentage of apoptotic cells. To confirm this estimate, we next quantified the number of YFP + neuroblasts along the SVZ-RMS axis and in the OB.
Genetic Removal of Functional NMDA Receptors Results in Decreased Neurogenesis
The density of YFP-expressing neuroblasts in the early rSVZ revealed that there was no significant difference in electroporation efficiency ( Figures 8A and 8B , cell count normalized by the area). In addition, these data suggest that there is no defect in the ability of SVZ astrocyte-like stem cells to give rise to transit amplifying cells that generate neuroblasts. In contrast, cell counting revealed that there was a significant decrease in the density of YFP-expressing neuroblasts in the RMS of NR1 fl / R26R-YFP mice (red bars) compared with control mice (black bars) at every time point (25%-35% decrease, p < 0.05, Figures  8A and 8B) . The ratio of the cell density in the NR1 fl /R26R-YFP mice over those in R26R-YFP mice gave a 25%-35% decrease in the number of NR1-KO neuroblasts that reaches the RMS ( Figure 8C ). In the RMS, neuroblasts are in transit to the OB and accumulate in the granule cell layer. It is thus not surprising that cell loss in the RMS was accompanied by a significant decrease (>40%) in the density of YFP-expressing neurons in the granule cell layer at every time point, culminating to an $65% decrease at 8 weeks. Collectively, these data show that genetic removal of NMDARs in neuroblasts results in apoptosis during their migration to the OB prior to synaptic integration, and thus, a significant reduction in neurogenesis. Therefore, signaling via NMDARs provides an important in vivo survival cue for neuroblasts even before they assume their roles as interneurons in the OB circuitry.
DISCUSSION
We show here that Ca 2+ activity in SVZ/ RMS astrocytes governs glutamate signaling in the neurogenic forebrain and induces phasic NMDAR activation in neuroblasts in the absence of synapses. We also identify a primary role of this signaling in early survival of migrating neuroblasts through NMDARs. Genetic removal of NMDARs in neuroblasts leads to the death of more than one-third of the neuroblasts born in the young adult brain, prior to entering a synaptic network.
Neuroblasts Acquire NMDARs during Migration in the rSVZ and Most Neuroblasts Display Spontaneous NMDAR Channel Activity in the RMS Our data from patch-clamp experiments show that neuroblasts express functional NMDARs earlier than previously thought (Carleton et al., 2003) , but are consistent with the presence of functional NMDARs in neurosphere cultures from the perinatal SVZ (Brazel et al., 2005) . Carleton et al. (2003) did not observe NMDA-induced currents in RMS OB neuroblasts presumably because neuroblasts were recorded in the whole-cell configuration, resulting in rundown of NMDA currents (Legendre et al., 1993) . Here, we used the perforated patch-clamp technique to keep the intracellular medium as intact as possible. We obtained relatively long recordings (>30 min) with stable NMDAR-mediated currents during the entire duration of recording. Recorded neuroblasts did not display functional NMDARs in the SVZ (i.e., along the lateral ventricle) although NR1 expression was observed in SVZ neuroblasts (Ná cher et al., 2007) . Rather, neuroblasts acquire functional NMDARs during their tangential migration in the rSVZ and $80% of neuroblasts display functional NMDARs as early as in the RMS EL . Experiments using genetic removal of functional NMDARs provide strong evidence that NMDA-induced currents were due to direct NMDAR activation in the recorded neuroblasts. We also found that the density of NMDARs increased in neuroblasts migrating along the RMS, suggesting that neuroblasts undergo a progressive differentiation, and are perhaps primed to integrate into the OB synaptic network. During development the NR2B subunit is the first to be expressed (Monyer et al., 1994) ; future studies will be required to determine the subunit composition of NMDARs in neuroblasts of the SVZ and RMS.
Neuroblasts also displayed spontaneous single-channel events sensitive to D-APV, identifying them as NMDAR-mediated events. Intriguingly, NMDAR channel activity was observed in the presence of a physiological Mg 2+ concentration, suggesting that these channels may have a low sensitivity to voltage-dependent Mg 2+ blockade. Future identification of the subunit composition will shed light on the Mg 2+ sensitivity.
Activity-Dependent Astrocyte-to-Neuroblast Glutamate Signaling in the SVZ and RMS
The presence of spontaneous NMDAR activity in neuroblasts suggests a phasic release of glutamate in the RMS. Our immunostaining data indicate that RMS astrocytes, but not neuroblasts, express VGLUT1 and synaptobrevin 2, and may thus be a source of vesicular glutamate. In addition, electron micrographs illustrated VGLUT1 nanogold particles on structures resembling vesicles (including fusing vesicles) in astrocytes. Consistent with this finding, selective Ca 2+ increase in RMS astrocytes in MrgA1 + mice induced glutamate release, resulting in NMDAR activation in surrounding neuroblasts. This finding is remarkable considering that selective Ca 2+ increase in mature astrocytes has failed to result in receptor activation in neurons in the hippocampus (Fiacco et al., 2007) . Such findings highlight the differences between regions predominated by asynaptic versus synaptic signaling. Consistent with VGLUT1 presence in SVZ/RMS astrocytes, data obtained with BoNT treatments suggest that vesicular release of glutamate from RMS astrocytes contributes to the phasic NMDAR activity in migrating neuroblasts. Indeed, blocking only neuronal release did not significantly affect NMDAR activity, while blocking both neuronal and astrocytic glutamate release with BoNT/B abolished NMDAR activity in neuroblasts. These data suggest a minor (if any) contribution from neuronal vesicular release to ambient glutamate level in the SVZ/RMS milieu. Therefore, our functional data are consistent with previous anatomical reports of a lack of axon terminals in the RMS (Lois et al., 1996) . The next step in elucidating intercellular signaling that regulates neurogenesis will be to investigate which signals control Ca 2+ activity in SVZ/RMS astrocytes and thus regulate glutamate release. For example, unpublished data from our lab suggest that GABA and prostaglandin E2 induce Ca 2+ increases in RMS astrocytes. It was also reported that GABA A receptors are tonically activated in RMS astrocytes and that blocking them results in a decrease in spontaneous Ca 2+ activity in SVZ astrocytes (Liu et al., 2005; Snapyan et al., 2009) . Collectively, our findings suggest that RMS astrocytes in the neurogenic zone are the major source of glutamate that contributes to phasic NMDAR activity in migrating neuroblasts.
Function of Glutamatergic Signaling on Olfactory Bulb Neurogenesis
Our data suggest that in the SVZ-to-RMS axis, NMDARs do not control the migration, but are important for the survival of neuroblasts. Pharmacologically blocking or activating NMDARs in acute slices did not affect the speed of neuroblast migration. Similarly, NR1-KO neuroblasts migrated at the same speed as control neuroblasts in acute slices. These results differ from findings in the neonatal cerebellum, where NMDARs tonically enhance the speed of granule cell precursor migration (Komuro and Rakic, 1993) and cortical progenitors (Behar et al., 1999) , but are consistent with the Ca 2+ independence of RMS neuroblast migration in the RMS OB (Darcy and Isaacson, 2009) .
Our main finding regarding apoptosis is that expression of functional NMDARs is critical for neuroblast survival during the long-distance migration from the SVZ to the RMS OB . This is a critical function of NMDARs in immature neurons prior to their entry into a synaptic network. Blockade of NMDARs in vivo resulted in a significant increase of apoptotic neuroblasts in the RMS where phasic NMDAR activation by ambient glutamate is higher compared with that in the rSVZ. Genetic NR1 removal and thus loss of functional NMDARs at the time of neuroblast birth resulted in apoptosis all along the rSVZ and RMS. These data suggest that a large proportion of neuroblasts that did not acquire NMDARs underwent apoptosis. Some NR1-KO neuroblasts escaped apoptosis possibly due to compensation through other glutamate receptors (Platel et al., 2007b; 2008b) . Alternatively, it is possible that only a subtype of adult-born neurons was affected by NMDAR removal. In addition to deficits in granule cells, there was a significant 54% decrease in the density of periglomerular cells in NR1 fl mice compared with control mice at 4 weeks (J.C.P. and A.B., unpublished data). Nevertheless, it is important to determine whether subpopulations of granule and periglomerular cells or glutamatergic neurons are selectively affected by NMDAR removal . Regarding the density data, it is intriguing that apoptosis at 2 weeks postelectroporation is less than that at 4 or 8 weeks. This may be due to the different cellular organization of the SVZ in neonates versus older mice (Peretto et al., 1997) ; neonates have a single chain of neuroblasts instead of multiple chains that are each ensheathed by astrocytes. As a result, the distance between neuroblasts to astrocytes is greater in neonatal tissue than in older tissue, and NMDAR may be less activated by ambient glutamate. The other finding not highlighted in the results is the significant increase in the number of apoptotic NR1-KO neurons in the granule cell layer compared with control neurons. These data match findings from previous studies in the perinatal cortex and the adult hippocampal neurogenic zone. It was reported that NMDA promotes the survival of neurons during synaptic integration in the perinatal cortex (Ikonomidou et al., 1999) and in the adult hippocampal granule cell layer (Tashiro et al., 2006) . One outcome predicted by the increased apoptosis is a decreased number of newly born neuroblasts and neurons. Indeed, cell counting highlighted a significant cell loss in the RMS and granule cell layer. The decrease in the number of neuroblasts was between 30%-40% at 4 and 8 weeks in the RMS. We cannot rule out that other developmental defects (e.g., proliferation; Gould et al., 1994; Cameron et al., 1995; Petrus et al., 2009) contribute to the decrease in cell number. Nevertheless, removal of NMDARs resulted in a significant decrease in neonatal and adult neurogenesis.
In conclusion, astrocyte-to-neuroblast glutamate signaling in the neurogenic SVZ/RMS region controls NMDAR activity in neuroblasts. This glutamatergic signal through NMDARs critically controls the number of neurons that ultimately reach the OB and are available to integrate into the existing synaptic network. These data suggest that acquisition of NMDARs en route to their final destination is necessary for proper genetic programming of cell survival and ongoing development. Experiments were performed at P19 -P30 in more than three mice unless otherwise noted (e.g. in vivo experiments were performed in more than four mice up to 8 weeks old). Acute sagittal slices containing the SVZ and RMS were prepared as previously described (Bolteus and Bordey, 2004 ) (see Supplemental Information). All experiments were in accordance with protocols approved by the Yale Animal Care and Use Committee.
Electrophysiology
Neuroblasts were recorded in sagittal sections using the gramicidin perforated patch-clamp technique as previously described (Wang et al., 2003b ) (see Supplemental Information). The recording aCSF contained (in mM) 126 NaCl, 2.5 KCl, 2 CaCl 2 , 1.25 NaH 2 PO 4 , 24 NaHCO 3 , and 10 glucose, and (in mM) 10 glycine, 20 bicuculline, and 10 strychnine (unless otherwise mentioned) (pH 7.4 when equilibrated with 95% O 2 /5% CO 2 ). The internal solution contained (in mM) 125 CsCl, 10 HEPES, 6 MgCl 2 , 2 EGTA, and 0.1 BaCl 2 (pH 7.3, 295-300 mOsmol). Single-channel data were analyzed for frequency using the single-channel and threshold detection functions in Clampfit 9 (Axon Instruments). The threshold amplitude was set between À1.8 and À2 pA.
Calcium Imaging
Cells were pressure loaded with Fluo-4 AM (1-2 min, 125 mM in DMSO with 20% Pluronic acid F-127). Ca 2+ imaging experiments were performed on an Olympus Fluoview 1000 confocal microscope equipped with a 60x objective (NA 0.9, WD 2 mm). Analysis of Ca 2+ data was performed in more than four slices from more than three mice with Calsignal (Platel et al., 2007a) . F 0 and F are the mean fluorescence intensities measured through all the regions of interest and in a single cell, respectively. A change in fluorescence was considered to be a Ca 2+ increase if F/F 0 > 20%.
Immunohistochemistry
Immunostaining performed in free-floating 100 mm thick slices was as previously described (Platel et al., 2009 ). The primary antibodies included rabbit anti-GFAP (1:1000, Dako), goat anti-DCX (1:100, Santa Cruz), chicken anti-GFP (1:500, Abcam), guinea pig anti-GLAST (1:500, Chemicon, USA), mouse anti-synaptobrevin 2 (1:100), rabbit anti-VGLUT1, 2, or 3 (1:1000, Synaptic Systems and NeuroMab), and rabbit anti-activated caspase 3 (1:500, Cell Signaling Technology).
Pre-Embedding Immunocytochemistry for L-Glutamate and Postembedding Immunogold Labeling for VGLUT1 These methods were as previously described (Rubio and Wenthold, 1999; Rubio and Juiz, 2004 ) (see Supplemental Information).
NMDAR Blockade In Vivo P20-P30 DCX-GFP transgenic mice received a single intraperitoneal injection of 100 ml saline (control) or 100 ml of saline solution containing 1 mg/kg body weight of MK-801. Mice were sacrificed 2, 6, or 24 hr after the injection as described above (n = 4 mice per time point per condition).
Postnatal In Vivo Electroporation
A pCAG-Cre:GFP plasmid (5 mg/ml, Addgene, Matsuda and Cepko, 2007) was diluted in PBS containing 0.1% fast green as a tracer. Point five to one microliters of plasmid solution was injected into the lateral ventricle using a pulled glass pipette (beveled to a diameter of less than 50 mm) in pups anesthetized on ice. After plasmid injection using manual pressure, tweezer-type electrodes (model 520, BTX) were placed on the heads of the P0-P1 pups, and five square-pulses of 50 ms duration with 950 ms intervals at 150V were applied using a pulse ECM830 BTX generator.
Neuroblast Migration R26R-YFP mice (P20-P30) that received Cre-containing plasmids at P1 (electroporation) were used for examining neuroblast migration. Migration movies were acquired at 37 C on the Olympus confocal microscope with a Super 20x objective (NA 0.95) in high glucose DMEM using acute sagittal slices as previously described (Platel et al., 2008b ) (see Supplemental Information). to ten sections) of three square fields of view were obtained per region using a 20x objective (NA, 0.75). Cell number divided by volume yielded cell density. In Figure 8C , the cell density was normalized by the number of YFP + neuroblasts in the rSVZ, yielding a normalized cell density. The latter normalization was performed to correct for slight variation introduced by variability in electroporation efficiency. Nevertheless, cell density in the rSVZ was not significantly different.
Neuroblast Count
Drugs
See Supplemental Information.
Statistical Analysis
Statistical significance was determined using the two-tailed Student's t test (p < 0.05) unless otherwise noted. Data are presented as mean ± standard error of the mean (SEM).
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